Welcome to the archives of the International Journal of Research and Innovations in Pharmacy Practice (IJRIPP). This section provides access to all past issues of the journal, showcasing a wealth of research articles, reviews, and other valuable contributions in the field of pharmacy practice.
Explore Past Issues
Volume 2
Issue 1 JANUARY- JUNE 2025
Volume 2(Issue 1) JANUARY- JUNE 2025 Research Articles
Influence of Insurance Structure on Drug Development and Pricing Strategies
Vol.2(1); Pages:1-9. Published on April 2025
Abstract
Insurance design structures determine both pharmaceutical innovation development and the strategic pricing of drugs in the market. Pharmaceutical companies have stronger motivations to invest in research and development because insurance coverage arrangements determine how various fees such as copayments and deductibles affect them. Health insurance systems with extensive high-cost drug coverage tend to promote drug innovation while possibly causing medication price increases. Market demand changes due to limited patient access from restrictive insurance models with cost-sharing provisions which in turn transforms the research and development strategies of pharmaceutical companies. The research investigates the complex relationship between insurance coverage policies and pharmaceutical product advancement processes while evaluating their monetary implications. The interactions between health insurance policies and pharmaceutical development require full comprehension by government officials who need to find equilibrium between affordability and medical improvement and patient healthcare access.
View Full PDF
Please LOGIN to View Full PDF or Read more.
The Growth and Influence of Clinical Informatics in Contemporary Healthcare
Vol.2(1); Pages:10-15. Published on April 2025
Abstract
Healthcare has developed Clinical Informatics as a fundamental specialty to connect IT systems and data analytics with medical care delivery. The interdisciplinary field investigates data processing strategies for EHRs and AI systems and big data methods to boost medical care quality and operational procedures while enhancing clinical choices. Clinical Informatics achieved recognition as an individual specialty practice because it plays an essential role in advancing evidence-based medicine and precision healthcare and multidisciplinary teamwork. Healthcare systems increasing digitization leads Clinical Informatics professionals to take central positions in developing innovative patient safety solutions while minimizing medical errors and maintaining connection between various healthcare systems. This paper evaluates the historical development of clinical informatics together with its effects on patient results and also examines the implementation of AI and machine-learning and analyzes cybersecurity alongside data privacy and regulatory difficulties. Healthcare providers alongside policymakers and technologists together with clinical informaticians can construct a patient-oriented data-based efficient healthcare system since they grasp the technological transformation potential of Clinical Informatics.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Economic Efficiency of Pharmacy-Led Self-Care for Minor Illnesses in Germany’s Healthcare System
Vol.2(1); Pages:16-21. Published on April 2025
Abstract
Pharmacological self-care services available in pharmacies help decrease healthcare system demands through their patient-centered and budget-friendly medical solutions. Researchers studied cost management of self-care procedures inside German pharmacies in contrast to regular doctor check-ups. The examination includes both medical costs involving direct expenses and secondary expenses in addition to assessment of patient success as well as whole system operational performance. Pharmacy-led self-care promotion activities demonstrate potential to lower healthcare costs while improving care system efficiency and client convenience while maintaining quality of services. The implementation success of this strategy depends on proper regulation and required patient teaching and skilled participation from pharmacy professionals.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Improving Pharmaceutical Supply Chain Security and Drug Traceability Using Blockchain Technology
Vol.2(1); Pages:22-29. Published on April 2025
Abstract
Modern pharmaceutical industry progressed with blockchain technology because this enables transparent drug tracking and fortified supply chain security together with better regulatory adherence. The combination of decentralized and immutable ledger infrastructure allows pharmaceutical companies to achieve open visibility which diminishes illegal pharmaceutical products throughout their entire manufacturing and distribution process. Smart contracts enhance automation of transactions which results in greater operational efficiency and minimized fraudulent activities. The paper examines blockchain technology’s abilities to protect pharmaceutical network supply chains while improving medical safety protocols and regulatory compliance compliance measures. This paper discusses the scalability limitations and system integration obstacles and regulatory barriers that exist in addition to future blockchain-powered innovation opportunities within pharmaceutical industries.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Revamping Pharmacology Education: Strategies for Teaching Reform in a Changing Academic Landscape
Vol.2(1); Pages:30-35. Published on April 2025
Abstract
Higher education transformations coupled with educational improvements produce difficulties for traditional pharmacology course teaching methods to fulfill contemporary medical education requirements. The research investigates modern teaching approaches that aim to improve pharmacology instruction efficiency. A research study examines four areas of examination that consist of redesigned curricula and interdisciplinary content integration as well as digital education methods and practical training development. The evaluation of existing literature and field examples reveals that problem-based learning, flipped classrooms, simulation-based teaching and artificial intelligence tools are essential methods for improving student understanding and involvement in education. The evaluation includes assessment of both student critical thinking development and problem-solving enhancement together with clinical application skill development. Quality assessment methods along with competency-based education show importance to maintain the quality standards of pharmacology education. Research outcomes confirm that students achieve superior learning results when educational programs merge theoretical information with practical application because this methodностыlnodify professional skills after graduation. Educational institutions and teaching staff should use findings from this research to modernize pharmacology instruction within educational transformation contexts.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Volume 1
Issue 2 JULY – DECEMBER 2024
Research Articles Volume 1 (Issue 2) JULY – DECEMBER 2024
The Impact of Workflow Optimization on Patient Safety and Service Quality
Vol.1(2); Pages:1-8. Published on July 2024
Abstract
Pharmacy operations are fundamental to healthcare delivery, ensuring the accurate and timely dispensing of medications. However, inefficiencies and errors in pharmacy workflows can compromise patient safety and service quality. This study aims to evaluate the impact of workflow optimization on patient safety and service quality within pharmacy settings. By examining various methods for optimizing workflows, such as Lean Six Sigma, automation, and process reengineering, the study assesses their effectiveness in improving operational performance and patient outcomes. A comprehensive literature review was conducted, focusing on peer-reviewed articles and studies published in the last decade. Databases such as PubMed, Google Scholar, IE eXplore, and Scopus were searched using keywords including “pharmacy workflow optimization,” “process improvement,” “medication dispensing efficiency,” and “pharmacy automation.” Studies that met the inclusion criteria were analysed to identify common themes and outcomes related to workflow optimization in pharmacy settings. The review identified several key methods for workflow optimization, including Lean Six Sigma, automation, and process reengineering. Studies consistently demonstrated that these methods lead to significant improvements in efficiency, reducing wait times for patients and increasing the accuracy of medication dispensing. Moreover, optimized workflows were associated with a substantial reduction in medication errors, enhancing patient safety. Staff satisfaction also improved due to better workload distribution and reduced stress levels.
View Full PDF
Please LOGIN to View Full PDF or Read more.
The Role of Pharmacy Information Systems in Enhancing Medication Safety and Patient Care
Vol.1(2); Pages:9-17. Published on August 2024
Abstract
Pharmacy Information Systems and Technology represent a cornerstone of modern pharmacy practice, revolutionizing the way pharmacists deliver care, streamline workflows, and empower pharmacists to provide personalized pharmaceutical care tailored to individual patient needs. From medication reconciliation processes to medication adherence monitoring, patient engagement tools, and the integration of artificial intelligence, Pharmacy Information Systems play a crucial role in promoting medication safety, improving medication outcomes, and driving continuous quality improvement in healthcare delivery. The integration of advanced technologies such as artificial intelligence, predictive analytics, and telepharmacy services within Pharmacy Information Systems enables pharmacists to make evidence-based decisions, optimize medication therapy outcomes, and engage with patients remotely to provide medication counseling and support. By harnessing the power of data analytics, pharmacists can track performance metrics, monitor medication outcomes, and demonstrate the value of pharmaceutical care services in improving patient health outcomes and healthcare quality. By focusing on these key areas, pharmacists can leverage digital innovations, technological advancements, and data-driven solutions to optimize medication management practices, enhance patient care delivery, and shape the future of pharmacy practice to meet the evolving needs of patients, healthcare systems, and the broader healthcare landscape.
View Full PDF
Please LOGIN to View Full PDF or Read more.
A Clinical Pharmacy Team’s Function and Influence at an Inflammatory Bowel Disease Center
Vol.1(2); Pages:18-25. Published on October 2024
Abstract
The role and impact of a clinical pharmacy team at an Inflammatory Bowel Disease (IBD) Center are vital in optimizing medication management, enhancing patient outcomes, and ensuring the comprehensive care of individuals with IBD. Clinical pharmacists play a crucial role in the multidisciplinary team, contributing their expertise to the management of complex treatment regimens, patient education, and adherence strategies. This team works closely with gastroenterologists, nurses, dietitians, and psychologists to provide personalized care plans, monitor drug interactions, adjust therapies for effectiveness, and manage side effects. Their function extends beyond medication management; they also support the integration of pharmacogenomics in treatment decisions, thus tailoring therapy to individual patient profiles. Clinical pharmacy teams facilitate shared decisionmaking with patients, addressing concerns related to treatment choices and potential side effects. Through regular follow-up and monitoring, they play a key role in preventing disease flares and reducing the need for hospitalization and surgery. The impact of clinical pharmacy services at an IBD center has been shown to improve adherence to treatment, enhance quality of life, and reduce healthcare costs. As the field of IBD treatment advances, the role of clinical pharmacy teams continues to evolve, adapting to new therapies and contributing to better patient outcomes through enhanced communication, education, and coordination of care.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Developing an Ethics Action Plan for Rare Disease Care: A Participatory Action Research Approach
Vol.1(2); Pages:26-35. Published on November 2024
Abstract
Rare diseases present complex challenges, encompassing medical, ethical, and social dimensions that demand innovative and inclusive solutions. With patients often facing delayed diagnoses, limited treatment options, and insufficient support, the ethical considerations surrounding rare disease care require urgent attention. This study aims to develop an Ethics Action Plan specifically tailored to rare disease care using a Participatory Action Research (PAR) approach. PAR emphasizes collaboration and inclusivity, actively engaging diverse stakeholders including patients, caregivers, healthcare professionals, researchers, and policymakers in co-creating solutions. The study adopts a cyclical process of reflection, action, and learning to address critical areas such as equitable access to diagnostics and therapies, prioritization of funding for rare disease research, and the empowerment of patient voices in care decisions.The Ethics Action Plan focuses on integrating ethical principles, such as justice, beneficence, and autonomy, into rare disease care frameworks while fostering sustainable, patient-centered solutions. It also seeks to identify and mitigate barriers to care, ensuring culturally sensitive and context-specific interventions. By leveraging the strengths of PAR, the plan aspires to establish a dynamic, adaptable model that aligns with the evolving needs of the rare disease community. The outcomes of this initiative hold potential not only for improving ethical standards in rare disease care but also for influencing broader healthcare practices.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Rare Diseases as a Global Public Health Priority: Challenges and Opportunities
Vol.1(2); Pages:36-43. Published on December2024
Abstract
Rare diseases, while affecting a small proportion of the global population, pose significant challenges to public health due to their complexity, the limited availability of effective treatments, and the knowledge gaps that exist regarding their diagnosis and management. As these diseases are often underfunded and understudied, they frequently receive insufficient attention in public health agendas. However, the increasing recognition of rare diseases as a global public health priority reflects a shift towards understanding their broader impact and the need for more comprehensive responses. This abstract discusses the multifaceted challenges associated with rare diseases, including diagnostic delays, limited treatment options, disparities in access to care, and the economic burden they impose. It also highlights the opportunities for progress through advancements in genomics, international collaborations, and patient-centered approaches. By addressing these challenges and leveraging the emerging opportunities, there is potential to significantly improve the quality of life for those affected by rare diseases and to enhance global health systems’ capacity to respond to this growing issue.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Issue 1 JANUARY – JUNE 2024
Research Articles Volume 1 (Issue 1) JANUARY – JUNE 2024
Optimizing Pharmacy Operations: Strategies for Efficiency and Quality Care
Vol.1(1); Pages:1-10. Published on April 2024
Abstract
The study highlights the importance of effective inventory management, regulatory compliance, and supply chain coordination in maintaining the availability and quality of medications. It also examines the role of emerging technologies such as, block chain in revolutionizing inventory control, demand forecasting, and real-time monitoring. By synthesizing insights from both operational and pharmacological perspectives, this paper aims to provide a comprehensive framework for improving efficiency, reducing costs, and ensuring the safe and effective delivery of pharmaceutical products. The findings underscore the necessity for healthcare providers, pharmacists, and managers to collaborate closely, leveraging their expertise to achieve excellence in both patient care and operational performance.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Pharmacy Safety Essentials and Protecting Patients and Ensuring Security
Vol.1(1); Pages:11-17. Published on May 2024
Abstract
This abstract explores the critical importance of maintaining security and ensuring safety in pharmacy services to protect patients and uphold professional standards. It highlights key strategies and best practices for enhancing security measures, preventing medication errors, and promoting a safe environment within the pharmacy setting. By focusing on patient safety initiatives, staff training, technology integration, and regulatory compliance, pharmacies can effectively mitigate risks, safeguard patient well-being, and deliver high-quality pharmaceutical care. This abstract underscores the significance of prioritizing security and safety in pharmacy operations to foster trust, enhance patient outcomes, and maintain a secure healthcare environment. . Collaborative efforts among stakeholders and regulatory bodies are essential to establishing robust standards and adapting to evolving security landscapes. This abstract underscores the critical importance of integrated security frameworks in maintaining safe and secure pharmacy environments amidst dynamic healthcare challenges. Pharmacy security service and safety are paramount in ensuring the protection of pharmaceutical assets and the well-being of pharmacy personnel and customers.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Requirements for Pharmacy Prescriptions
Vol.1(1); Pages:18-26. Published on May 2024
Abstract
Although prospective drug utilization review and patient counselling have long been recognized as professional and ethical responsibilities of pharmacists, the implementation of the Omnibus Budget Reconciliation Act of 1990 made them legal responsibilities. Ensuring the safety and effectiveness of prescription pharmaceutical care requires that all members of the prescriber-patient-pharmacist triad are equally informed about the therapeutic plan for which the pharmacist is professionally, ethically, and legally responsible for properly implementing. Providing pharmacists with the clinical indication or diagnosis is an important and long overdue first step. Sinfonia Rx, Pharmacy Quality Alliance, and the Arizona Department of Health Services, unrelated to this work. The other authors have nothing to disclose.
View Full PDF
Please LOGIN to View Full PDF or Read more.
Strategic Financial Management for Pharmacies and Best Practices and Case Studies
Vol.1(1); Pages:27-34. Published on June 2024
Abstract
Financial management plays a critical role in the successful operation of pharmacies, ensuring financial stability, efficiency, and the ability to provide quality patient care. This abstract explores the importance of financial planning, budgeting, cost control, and revenue optimization in pharmacy operations. It highlights the significance of integrating technology solutions, data analytics, and automation tools to streamline financial processes and enhance decision-making. The abstract also discusses future trends in financial management within pharmacy operations, including the potential benefits of artificial intelligence, blockchain technology, and sustainability initiatives. Overall, effective financial management in pharmacy operations is essential for navigating the complexities of the healthcare industry, adapting to regulatory changes, and achieving long-term financial sustainability.
View Full PDF
Please LOGIN to View Full PDF or Read more.
The effectiveness of clinical nurse educators in the teaching of treatment and pharmacology
Vol.1(1); Pages:35-44. Published on June 2024
Abstract
Absorption is the first stage of pharmacokinetics, which occurs when drugs enter the body and travel from the point of delivery to the bloodstream. Distribution is the second stage in pharmacokinetics. It is the mechanism by which medicine circulates throughout the body. Metabolism is the third stage of pharmacokinetics, which involves the breakdown of drug molecules. Excretion is the last stage of pharmacokinetics and refers to how the body eliminates waste. Each of these stages is discussed separately in the next sections of this chapter. Pharmacokinetics researchers must consider another aspect of drug activity in the body: time. Scientists are unable to visualize where a medicine is going or how long it will be active. To compensate, they utilize mathematical models and accurate blood and urine tests to estimate where a medicine travels and how much of the drug (or breakdown product) remains after the body processes it. Other signs, such as blood levels of liver enzymes, can aid in predicting how much a medicine will be absorbed.
View Full PDF
Please LOGIN to View Full PDF or Read more.
By exploring our archives, you can stay informed about the progression of pharmacy practice research and gain valuable insights into historical and current trends.
To access a specific issue, simply browse through the archive list and select the desired volume and issue number. Each issue contains a table of contents with links to individual articles for easy access.
We are committed to preserving the rich history of pharmacy practice research and providing a platform for future scholarship. Thank you for your interest in our journal’s archives.
